title: Control of follicular development and luteal function in the mare: effects of a GnRH antagonist.
abstract: Control of the equine estrous cycle was studied by suppressing gonadotropin secretion by administration of a GnRH antagonist to cyclic pony mares. Four mares received vehicle (control cycle) or a GnRH antagonist, Antarelix (100 microg/kg) on Day 8 of diestrus, and blood samples were collected at 15-min intervals from 0 to 16 h, 24 to 36 h, and daily until the next ovulation. Ovarian activity was monitored by transrectal ultrasonography, and measurement of plasma concentrations of progesterone and estradiol. Antagonist treatment eliminated large diestrous pulses of LH. Progesterone concentrations had fallen significantly in all mares by the day after treatment and, in three of the four mares, remained low until luteolysis. However timing of luteolysis (ie., progesterone concentrations <1 ng/mL) was not affected by antagonist treatment. The preovulatory surges of estradiol and LH were significantly delayed in the treatment cycle, as was the appearance of a preovulatory follicle >30 mm. Cycle length was significantly longer during the treatment than the control cycle. These results show that treatment of diestrous mares with a GnRH antagonist attenuated progesterone secretion, indicating a role for LH in control of CL function in the mare, and delayed ovulation presumably because of lack of gonadotropic support.
authors.affiliation: University of Edinburgh, Department of Veterinary Clinical Studies, Roslin, Midlothian, UK.
authors.forename: E D
authors.initials: ED
authors.lastname: Watson
authors.forename: H G
authors.initials: HG
authors.lastname: Pedersen
authors.forename: S R
authors.initials: SR
authors.lastname: Thomson
authors.forename: H M
authors.initials: HM
authors.lastname: Fraser
mesh_terms: D000818:Animals; D003338:Corpus Luteum / Q000187:drug effects / Q000502:physiology*; D004971:Estrus; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006727:Hormone Antagonists / Q000494:pharmacology*; D006736:Horses / Q000502:physiology*; D007986:Luteinizing Hormone / Q000097:blood; D009842:Oligopeptides / Q000494:pharmacology*; D006080:Ovarian Follicle / Q000187:drug effects / Q000254:growth & development*; D010052:Ovariectomy; D011374:Progesterone / Q000097:blood
chemical_list: D006727:Hormone Antagonists; D009842:Oligopeptides; D011374:Progesterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; C084350:antarelix